MDMA Moves from Party Drug Back to Thera...

Presidential physicians operate at the intersection of medicine, politics and national security. Former White House physician Jeffrey Kuhlman joins Scientific American associate editor Lauren Young to discuss the unique medical demands of presidential care—from preparing for emer ... Show More

What happens when a real-life astronaut turns to fiction? In this episode, Chris Hadfield shares how decades of spaceflight and global diplomacy inspired his latest novel, Final Orbit, a cold war thriller packed with historical intrigue and technical precision. Host Rachel Feltma ... Show More

Saturn’s moon Enceladus reveals complex organic molecules that could hint at extraterrestrial life. Researchers also uncover fungi’s ancient reign over Earth and warn that second COVID infections may pose greater risks to young people. Plus, ants ferment yogurt, and flu detection ... Show More

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ... Show More

In this episode, I discuss Methyl​enedioxy​methamphetamine (MDMA), which is also commonly known as “ecstasy” or “molly,” including how it works in the brain to cause short- and long- term-shifts in emotional processing and its clinical applications for the treatment of post-traum ... Show More

Once a party drug, ketamine has found its way into modern medicine. 

In the form of recreational ecstasy, the psychoactive drug MDMA carries with it a stigma of wide-eyed ravers, free love and counterculture pharmacological spirituality. But beyond its cultural legacy, MDMA offers a potent therapeutic tool for doctors and therapists -- if we can o ... Show More

In this episode, Rick Doblin, founder and executive director of MAPS, discusses MDMA, a molecule that has (at a minimum) revolutionary therapeutic benefits for PTSD, but arguably could have, at the highest order, a lasting impact on humanity’s ability to peacefully coexist. Rick ... Show More

In this episode, Kyle and Joe interview Ben Sessa, a Consultant Psychiatrist. Ben comes on the show to talk about preliminary results from the first ever, MDMA assisted therapy for alcohol use disorder (AUD). 3 Key Points: Ben Sessa plays a role in leading the current MDMA assist ... Show More

Molly, ecstasy, MDMA: whatever you call it, this drug is blowing up. Some say MDMA can be a legitimate medicine to treat conditions like PTSD. But others reckon it's a dangerous drug that can fry your brain, and even kill you — from just one bad pill. Who's right? That's what we' ... Show More

Psychedelics have gotten very popular in the past few years for their therapeutic properties, but how much do you know about them? In this episode, I am going to talk about MDMA, which has a better success rate for PTSD than anything... ever! If all goes well with the FDA trials, ... Show More

It ain’t easy getting old but the right drugs, used in the right ways, can help. Charley Wininger is a psychotherapist, called “The Love Doctor,” who recently authored of Listening to Ecstasy: The Transformative Power of MDMA. I talked with him and his wife, Shelley, about the wa ... Show More